Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 9.56
+0.07 (0.74%)
Aug 19, 2025, 11:44 AM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 17.12 billion as of August 18, 2025. Its market cap has increased by 251.25% in one year.
Market Cap
17.12B
Enterprise Value
17.50B
Revenue
391.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.56
Market Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has increased from 11.84B to 17.12B, an increase of 44.60%. That is a compound annual growth rate of 11.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 17.61B | 292.95% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 276.65B |
| Hansoh Pharmaceutical Group Company | 221.78B |
| JD Health International | 196.01B |
| Innovent Biologics | 166.99B |
| Akeso | 148.55B |
| Sino Biopharmaceutical | 139.86B |
| WuXi Biologics | 125.94B |
| CSPC Pharmaceutical Group | 125.31B |